What is the appropriate workup for an adult patient with suspected sepsis-associated disseminated intravascular coagulation (DIC)?

Workup for Sepsis-Associated DIC

Screen all septic patients using the Sepsis-Induced Coagulopathy (SIC) scoring system first, then confirm overt DIC with ISTH criteria if SIC is positive—this two-step approach enables early detection and guides anticoagulant therapy decisions. 1

Initial Laboratory Panel (SIC Screening)

Obtain these three readily available tests to calculate the SIC score:

• Complete blood count with platelet count – thrombocytopenia is the most sensitive early marker of sepsis-associated coagulopathy and correlates with mortality 1
• Prothrombin time (PT) with INR – PT prolongation increases linearly with sepsis severity, unlike fibrin markers which plateau due to suppressed fibrinolysis 1
• Sequential Organ Failure Assessment (SOFA) score – already calculated in septic patients; incorporates respiratory, cardiovascular, hepatic, and renal dysfunction 1

Do not order fibrinogen or D-dimer for initial SIC screening—these markers are deliberately excluded because fibrinogen remains normal or elevated in sepsis (acute-phase reactant) and D-dimer does not correlate with disease severity due to suppressed fibrinolysis. 1

SIC Scoring Algorithm

Calculate the SIC score using this point system (total ≥4 = positive):

• Platelet count:

  • <100 × 10⁹/L = 2 points
  • 100–149 × 10⁹/L = 1 point 1, 2

• PT-INR:

  • 1.4 = 2 points

  • 1.2–1.4 = 1 point 1, 2

• SOFA score:

  • ≥2 = 2 points
  • 1 = 1 point 1, 2

A score ≥4 identifies the compensated phase of DIC with ≥30% mortality and warrants consideration of anticoagulant therapy. 1, 2 Approximately 60% of septic patients meet SIC criteria, double the rate of overt DIC. 1, 2

Confirmatory Testing for Overt DIC (If SIC Positive)

When SIC score ≥4, proceed to ISTH overt DIC scoring (total ≥5 = overt DIC):

• Platelet count:

  • <50 × 10⁹/L = 2 points
  • 50–99 × 10⁹/L = 1 point 1, 2

• Fibrin-related markers (D-dimer or FDP):

  • Strong increase (typically D-dimer >5× upper limit normal) = 3 points
  • Moderate increase (typically D-dimer 2–5× upper limit normal) = 2 points 1, 2

• PT prolongation:

  • ≥6 seconds above normal = 2 points
  • 3–5 seconds above normal = 1 point 1, 2

• Fibrinogen:

  • <100 mg/dL (1.0 g/L) = 1 point 1, 2

Critical pitfall: Nearly all patients who develop overt DIC are first identified by SIC criteria—waiting for overt DIC delays therapeutic intervention. 1, 2

Monitoring and Repeat Testing

• Repeat SIC and DIC scoring every 24–48 hours in patients with initial SIC score ≥4 to track progression from compensated to decompensated coagulopathy 2, 3
• Daily platelet counts and PT-INR are sufficient for monitoring in most cases; reserve fibrinogen and D-dimer for overt DIC confirmation 1
• SIC sensitivity for predicting mortality exceeds overt DIC at all time points (86.8% vs 64.5% at baseline; 96.1% vs 67.1% on day 2), making it the superior screening tool 4

Additional Diagnostic Considerations

• Exclude thrombotic microangiopathy (TMA) if schistocytes are present on blood smear with disproportionate hemolysis relative to coagulation abnormalities 5
• Exclude heparin-induced thrombocytopenia (HIT) if platelet drop occurs 5–14 days after heparin exposure with thrombotic complications 5
• Assess for symmetrical peripheral gangrene (SPG) by examining distal extremities for acral necrosis—this microvascular thrombosis complication occurs with severe protein C depletion during acute hepatic dysfunction 6, 7

Evidence Strength and Nuances

The SIC criteria were developed by the ISTH Scientific and Standardization Committee specifically to enable earlier DIC detection in sepsis using only routine tests. 1 The 2023 ISTH consensus statement emphasizes that SIC identifies the compensated phase while ISTH overt DIC identifies the decompensated phase—both are part of the same disease spectrum. 1

Key advantage of SIC: Simplicity and speed—no need for fibrinogen or fibrin markers, which are expensive, not universally available, and lack standardized cutoffs across assays. 1 The Japanese Society on Thrombosis and Hemostasis 2024 guidelines endorse multiple DIC criteria (JAAM, ISTH, SIC, JSTH) but recommend selecting criteria based on diagnostic properties—SIC excels for early sepsis screening. 8

Comparative performance: A 2024 study comparing five DIC criteria in septic patients found KSTH had 95.4% sensitivity but only 7.3% specificity, while ISTH balanced sensitivity (69.4%) and specificity (48.5%) better. 9 SIC was not included in that comparison but outperforms ISTH for early detection per the 2020 prospective study showing 98.7% of overt DIC patients had prior SIC diagnosis. 4